Sumit K. Shah
Research Assistant
Also affiliated: Stevens Institute of Technology (1999); University of California, Los Angeles (2004–2011); University of Arkansas Medical Center (2021); Indus Hospital (2011); Muhlenberg Regional Medical Center (1999)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Sumit K. Shah's research primarily investigates public health issues related to infectious diseases and health disparities, with a particular focus on COVID-19 and vaccination. His work has examined the sociodemographic factors influencing vaccine hesitancy and the experiences of discrimination among Black adults in relation to COVID-19 vaccination.
Shah also has a background in medical imaging, with publications on computer-aided detection and characterization of lung nodules in CT scans. His earlier work explored quantitative texture-based assessments of fibrotic patterns in scleroderma lung disease and the classification of parenchymal abnormalities using denoising techniques. He has also contributed to systematic reviews on community-based programs aimed at reducing cancer health disparities.
His scholarly output includes 62 publications with over 1,254 citations, and he holds an h-index of 21. Shah leads a research group and collaborates with several researchers at the University of Arkansas for Medical Sciences, including Pearl A. McElfish, James P. Selig, and Don E. Willis, as well as Sharon Reece from the University of Arkansas at Fayetteville.
Metrics
- h-index: 21
- Publications: 61
- Citations: 1,254
Positions
-
Research Assistant 2018–presentUniversity of Arkansas for Medical Sciences Pathology Institutional directory
Selected Publications
-
Correction: Associations Between General Vaccine Hesitancy and Healthcare Access Among Arkansans (2025)
-
Corrigendum to “COVID-19 vaccine hesitancy and racial discrimination among US adults” [Pre. Med. Rep. 31 (2022) 102074] (2025)
-
Acute Myeloid Leukemia with Hemophagocytosis: Diagnostic Cues and Potential Pitfalls. (2025)PubMed OpenAlex
-
A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida (2025)
-
Evusheld, a SARS-CoV-2 spike protein–directed attachment inhibitor, appears in serum protein electrophoresis and immunofixation: a case study (2023)
-
A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023)
-
Factors associated with breast cancer screening services use among women in the United States: An application of the Andersen's Behavioral Model of Health Services Use (2023)
-
Comparing community-driven COVID-19 vaccine distribution methods: Faith-based organizations vs. outpatient clinics (2022)
-
COVID-19 vaccine hesitancy and racial discrimination among US adults (2022)
-
Associations Between General Vaccine Hesitancy and Healthcare Access Among Arkansans (2022)
-
Assessment of Colorectal Cancer Screening Disparities in U.S. Men and Women Using a Demographically Representative Sample (2022)
-
Associations between 5-year influenza vaccination and sociodemographic factors and healthcare access among Arkansans (2022)
-
Parent/guardian intentions to vaccinate children against COVID-19 in the United States (2022)
-
COVID-19 Vaccine Hesitancy and Experiences of Discrimination Among Black Adults (2022)
-
Parents’ and Guardians’ Intentions to Vaccinate Children against COVID-19 (2022)
Collaboration Network
Top Collaborators
- Sociodemographic Determinants of COVID-19 Vaccine Hesitancy, Fear of Infection, and Protection Self-Efficacy
- COVID-19 Vaccine Hesitancy and Experiences of Discrimination Among Black Adults
- COVID-19 vaccine hesitancy and racial discrimination among US adults
- Assessment of Colorectal Cancer Screening Disparities in U.S. Men and Women Using a Demographically Representative Sample
- “The Risk Seems Too High”: Thoughts and Feelings about COVID-19 Vaccination
Showing 5 of 16 shared publications
- Sociodemographic Determinants of COVID-19 Vaccine Hesitancy, Fear of Infection, and Protection Self-Efficacy
- COVID-19 Vaccine Hesitancy and Experiences of Discrimination Among Black Adults
- COVID-19 vaccine hesitancy and racial discrimination among US adults
- “The Risk Seems Too High”: Thoughts and Feelings about COVID-19 Vaccination
- Parent/guardian intentions to vaccinate children against COVID-19 in the United States
Showing 5 of 10 shared publications
- Sociodemographic Determinants of COVID-19 Vaccine Hesitancy, Fear of Infection, and Protection Self-Efficacy
- COVID-19 Vaccine Hesitancy and Experiences of Discrimination Among Black Adults
- COVID-19 vaccine hesitancy and racial discrimination among US adults
- Parent/guardian intentions to vaccinate children against COVID-19 in the United States
- Parents’ and Guardians’ Intentions to Vaccinate Children against COVID-19
Showing 5 of 10 shared publications
- COVID-19 vaccine hesitancy and racial discrimination among US adults
- Parent/guardian intentions to vaccinate children against COVID-19 in the United States
- Parents’ and Guardians’ Intentions to Vaccinate Children against COVID-19
- Associations Between General Vaccine Hesitancy and Healthcare Access Among Arkansans
- Associations between 5-year influenza vaccination and sociodemographic factors and healthcare access among Arkansans
Showing 5 of 8 shared publications
- Meta-Analysis Comparing WatchmanTM and Amplatzer Devices for Stroke Prevention in Atrial Fibrillation
- QT prolongation in HIV-positive patients: Review article
- Meta‐analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy
- Outcomes of uninterrupted vs interrupted Periprocedural direct oral Anticoagulants in atrial Fibrillation ablation: A meta‐analysis
- Complex Left Atrial Appendage Morphology Is an Independent Risk Factor for Cryptogenic Ischemic Stroke
Showing 5 of 7 shared publications
- Examining aspects of successful community-based programs promoting cancer screening uptake to reduce cancer health disparity: A systematic review
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- An Online Survey and Focus Groups for Promoting Cancer Prevention Measures
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
Showing 5 of 7 shared publications
- Examining aspects of successful community-based programs promoting cancer screening uptake to reduce cancer health disparity: A systematic review
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- COVID-19 Vaccine Hesitancy and Experiences of Discrimination Among Black Adults
- COVID-19 vaccine hesitancy and racial discrimination among US adults
- Parent/guardian intentions to vaccinate children against COVID-19 in the United States
- Parents’ and Guardians’ Intentions to Vaccinate Children against COVID-19
- Corrigendum to “COVID-19 vaccine hesitancy and racial discrimination among US adults” [Pre. Med. Rep. 31 (2022) 102074]
- Loss of C/EBPδ enhances IR-induced cell death by promoting oxidative stress and mitochondrial dysfunction
- C/EBPδ protects from radiation-induced intestinal injury and sepsis by suppression of inflammatory and nitrosative stress
- Cebpd Is Essential for Gamma-Tocotrienol Mediated Protection against Radiation-Induced Hematopoietic and Intestinal Injury
- Therapeutic potential of natural plant products and their metabolites in preventing radiation enteropathy resulting from abdominal or pelvic irradiation
- Meta-Analysis Comparing WatchmanTM and Amplatzer Devices for Stroke Prevention in Atrial Fibrillation
- Meta‐analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy
- Outcomes of uninterrupted vs interrupted Periprocedural direct oral Anticoagulants in atrial Fibrillation ablation: A meta‐analysis
- Outcomes of Uninterrupted vs Interrupted Periprocedural Direct Oral Anticoagulants in Atrial Fibrillation Ablation: A Meta-Analysis
- Meta-Analysis Comparing WatchmanTM and Amplatzer Devices for Stroke Prevention in Atrial Fibrillation
- Meta‐analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy
- Outcomes of uninterrupted vs interrupted Periprocedural direct oral Anticoagulants in atrial Fibrillation ablation: A meta‐analysis
- Outcomes of Uninterrupted vs Interrupted Periprocedural Direct Oral Anticoagulants in Atrial Fibrillation Ablation: A Meta-Analysis
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3).
- Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
Similar Researchers
Based on overlapping research topics